Produkty 13201-14-4

CAS 13201-14-4 występuje w naszej ofercie pod nazwami: Dihydrocucurbitacin B/ 98.67% (existing batch purity), Dihydrocucurbitacin B, Dihydrocucurbitacin B, 96.76%. Oferty producentów: TargetMol, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 5 mg, 10 mg.

Dihydrocucurbitacin B/ 98.67% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 5
od 810,99
Zobacz produkt
Dihydrocucurbitacin B
Biosynth, Chemat
  • opakowanie: 25mg, 10mg, 50mg, 1mg
  • Warianty: 8
od 626,00
Zobacz produkt
Dihydrocucurbitacin B, 96.76%
MedChemExpress
  • opakowanie: 5 mg, 10 mg
  • Warianty: 2
od 1801,13
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate (CAS 13201-14-4) to związek chemiczny o wzorze sumarycznym C32H48O8 i masie molowej 560.7 g/mol. Nazwa systematyczna IUPAC: [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate. InChIKey: QZJJDOYZVRUEDY-NRNCYQGDSA-N.

Dane identyfikacyjne
Wzór sumarycznyC32H48O8
Masa molowa560.7 g/mol
Nazwa IUPAC[(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate
InChIKeyQZJJDOYZVRUEDY-NRNCYQGDSA-N
SMILESCC(=O)OC(C)(C)CCC(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C[C@@H](C(=O)C4(C)C)O)C)C)C)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: DIHYDROCUCURBITACIN B, 23,24-dihydrocucurbitacin B, 23,24-dihydro-cucurbitacin B, Cucurbitacin B, dihydro-, 25-acetoxy-2beta,16alpha,20-trihydroxy-10alpha-cucurbit-5-ene-3,11,22-trione, orb1297396
Izomery (ten sam wzór sumaryczny)
[(E,6R)-6-hydroxy-2-methyl-5-oxo-6-[(2S,3S,8S,9R,10R,13R,14S,16R,17R)-2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-3-en-2-yl] acetate C32H48O8
[(1S,2S,6R,10S,11R,13S,14R,15R)-13-hexanoyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] hexanoate C32H48O8
[(E,6R)-6-[(3S,8S,9R,10R,13R,14S,16R,17R)-3,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate C32H48O8
[6-(3,16-dihydroxy-4,4,9,13,14-pentamethyl-2,11-dioxo-3,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate C32H48O8